Millipore Corp. buys out its Indian joint venture partner's 60 percent stake in Millipore India.
Millipore Corp. (NYSE:MIL) bought out the remaining 60 percent stake in its Indian subsidiary for an undisclosed amount.
The Billerica, Mass.-based lab instruments maker said the deal is part of its push into developing markets in Brazil, Russia, India, China and Singapore. Citing the more than 80 plants in India with U.S. Food & Drug Administration clearance to manufacture pharmaceuticals, Millipore said the country makes 25 percent of the world's generic drugs.
Millipore said its Indian subsidiary, Millipore India Pvt. Ltd., based in Bangalore, is largely a sales, service and manufacturing operation with roughly 300 employees. The segment also has operations in Ahmedabad, Hyderabad, Kolkata, Mumbai and Delhi.
Millipore posted $412 million in third-quarter sales, compared to $395 million for the same period last year, good enough to boost its bottom line about 4 percent. The company reported net income of $40 million, compared to $38 million for the same period last year.
A Synovis Life Technologies Inc. device designed to measure blood flow at anastomosis sites where...
Becton, Dickinson & Co. expands the Class I recall of millions of its Q-Syte Luer access...
First-quarter sales and earnings plummeted 81 and 93 percent, respectively, during the final three...
Sirona posted $31 million in first-quarter net income, up a whopping 460 percent, as Q1 sales rose to...
Former CoreValve CEO Dan Lemaitre will lead White Pine Medical, Essex Woodland Health's new...